MelatoninvsThymulin

Melatonin (N-acetyl-5-methoxytryptamine) is synthesized in the pineal gland from serotonin through a two-step pathway: N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin, and hydroxyindole O-methyltransferase (HIOMT) converts it to melatonin. AANAT activity is under direct control of the suprachiasmatic nucleus (SCN) master circadian clock — it is strongly suppressed by light (via the retinohypothalamic tract) and activated in darkness, creating the characteristic nocturnal melatonin surge that signals nighttime to every cell in the body.

Melatonin acts through two high-affinity G protein-coupled receptors: MT1 (MTNR1A) and MT2 (MTNR1B), both of which are Gi/o-coupled, inhibiting adenylyl cyclase and reducing cAMP when activated. MT1 receptors in the SCN mediate the acute sleep-promoting effect — their activation inhibits the firing rate of SCN neurons, reducing the alerting signal from the master clock and promoting sleepiness. MT2 receptors in the SCN mediate circadian phase-shifting — their activation during the biological evening advances the clock phase (useful for jet lag and delayed sleep phase), while activation during the biological morning delays it. This dual receptor mechanism explains why melatonin both promotes acute sleepiness and shifts circadian timing.

Beyond sleep, melatonin is one of the most potent endogenous antioxidants. It directly scavenges hydroxyl radicals, superoxide anions, hydrogen peroxide, and peroxynitrite through electron donation. Uniquely, melatonin's antioxidant cascade is amplified — its metabolites (cyclic 3-hydroxymelatonin, AFMK, AMK) are themselves antioxidants, so each melatonin molecule can neutralize up to 10 reactive oxygen species in a cascade. Melatonin also upregulates antioxidant enzymes (superoxide dismutase, glutathione peroxidase, catalase) and downregulates pro-oxidant enzymes (nitric oxide synthase, lipoxygenase). In the immune system, MT1 receptors on T helper cells, natural killer cells, and eosinophils modulate immune function — melatonin generally enhances Th1 cellular immunity, increases NK cell activity, and augments antibody responses to vaccination, which has led to interest in melatonin as an immunomodulator in aging and cancer.

Thymulin (also known as facteur thymique sérique, FTS) is a nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) that is unique among thymic hormones in requiring a zinc ion for biological activity. The zinc ion is coordinated by the asparagine (position 9), serine (position 4), and the N-terminal glutamic acid, creating a metallopeptide complex where the zinc is essential for the correct three-dimensional conformation needed for receptor binding. Without zinc, thymulin is biologically inactive — this zinc dependency has important implications for immune function in zinc-deficient individuals.

Thymulin is produced exclusively by thymic epithelial cells and is the only thymic hormone that is truly thymus-specific — its serum levels become undetectable after thymectomy (surgical thymus removal). It binds to high-affinity receptors on T-cell precursors (thymocytes) and mature T cells, promoting several key aspects of T-cell biology. It induces the expression of T-cell differentiation markers (CD2, CD3, CD4, CD8), driving immature thymocytes through the stages of T-cell maturation. It enhances the cytotoxic function of CD8+ T cells and the helper function of CD4+ T cells. It modulates the balance between T-helper and T-suppressor (regulatory) cell populations, promoting appropriate immune regulation.

Thymulin also modulates cytokine production — it promotes IL-2 secretion (essential for T-cell proliferation and the generation of effector T cells), enhances IFN-γ production (important for Th1 cellular immunity), and influences the balance of pro-inflammatory versus anti-inflammatory cytokines. Serum thymulin levels peak around puberty and decline progressively with age, becoming virtually undetectable by age 60 — mirroring the age-related involution of the thymus gland. This decline correlates closely with immunosenescence markers: reduced naive T-cell output, skewed CD4/CD8 ratios, impaired vaccine responses, and increased susceptibility to infections and cancer. Zinc supplementation alone can partially restore thymulin activity in zinc-deficient elderly individuals, highlighting the clinical importance of the zinc-thymulin interaction.